Photon counting detector CT contrast agent-reduced transcatheter aortic valve reconstruction planning: a comparative study - Report - MDSpire

Photon counting detector CT contrast agent-reduced transcatheter aortic valve reconstruction planning: a comparative study

  • By

  • Yannik C. Layer

  • Alexander Isaak

  • Narine Mesropyan

  • Patrick A. Kupczyk

  • Dmitrij Kravchenko

  • Marilia Voigt

  • Tatjana Dell

  • Julian A. Luetkens

  • Daniel Kuetting

  • May 6, 2026

  • 0 min

Share

Clinical Report: Contrast Agent-Reduced Photon Counting Detector CT for TAVR

Overview

This study evaluates the diagnostic performance of a reduced contrast media dose (RCD) protocol using photon-counting detector CT (PCDCT) for transcatheter aortic valve replacement (TAVR) planning. Results indicate that RCD can maintain diagnostic quality while minimizing contrast agent volume, addressing safety concerns in patients with impaired renal function.

Background

Transcatheter aortic valve replacement (TAVR) is a critical intervention for patients with severe aortic valve stenosis, particularly among the elderly. Pre-procedural CT imaging is essential for accurate anatomical assessment and planning. However, the use of iodinated contrast media poses risks, especially in patients with renal impairment, necessitating strategies to reduce contrast volume without compromising diagnostic quality.

Data Highlights

{'contrast_volume': {'SCD': 80, 'RCD': 52.5}, 'diagnostic_quality': {'SCD': 'Standard', 'RCD': 'Maintained'}}

Key Findings

  • RCD protocol reduced contrast media volume from 80 mL to 52.5 mL.
  • Diagnostic quality was maintained in the RCD group despite lower contrast usage.
  • PCDCT demonstrated improved iodine sensitivity compared to conventional CT.
  • Patients with impaired renal function benefit from reduced contrast exposure.
  • Environmental and safety concerns regarding contrast media are addressed with RCD protocols.

Clinical Implications

The implementation of reduced contrast media protocols in TAVR planning can enhance patient safety, particularly for those with renal impairment. Clinicians should consider adopting photon-counting detector CT techniques to optimize imaging while minimizing the risks associated with iodinated contrast agents.

Conclusion

The study supports the use of reduced contrast media in PCDCT for TAVR planning, highlighting its potential to maintain diagnostic quality while addressing safety concerns. Further research may solidify these findings in broader clinical practice.

Related Resources & Content

  1. European Radiology, 2023 -- Decreased Use of Contrast Agent in TAVR Planning via Spectral Detector CT
  2. European Radiology, 2025 -- Assessment of Aortic Valve Calcium Using Multiphase Imaging Techniques
  3. European Radiology, 2023 -- Evaluation of Coronary Stent Patency Using Ultra-High-Resolution Photon-Counting Detector CT
  4. European Radiology, 2024 -- High-Resolution 40 keV Virtual Monoenergetic Imaging via Spectral Photon-Counting CT
  5. 2025 ESC/EACTS Guidelines for the management of valvular heart disease, European Heart Journal
  6. EVOLUT LOW RISK: Self-Expanding TAVR vs. Surgery at Six Years, American College of Cardiology
  7. ACR Manual on Contrast Media
  8. 2025 ESC/EACTS Guidelines for the management of valvular heart disease | European Heart Journal | Oxford Academic
  9. EVOLUT LOW RISK: Self-Expanding TAVR vs. Surgery at Six Years in Low-Risk Patients With AS - American College of Cardiology
  10. ACR Manual on Contrast Media

Original Source(s)

Related Content